Global Markets Direct Research

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Reports
Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning. These reports include in-depth company reports such as Company Market Share reports, which give a detailed breakdown of revenues by market and region, and Company Asset Reports, which give details of companies’ key assets by geography.
Company Strategic Analysis Reports include in-depth value chain and SWOT analysis, while Company Financial Deal Profiles highlight key financial deals that have shaped the company. Global Markets Direct also produces a wide range of market reports giving access to high value unique databases of information, examples include historic and forecast asset reports and market share reports covering value, volume, distribution and company shares.

Sectors and Geographies Covered
Global Markets Direct specializes in the Energy and Medical Equipment Markets. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers.

Research Methodology
With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.
Global Markets Direct Research
 

List of reports from Global Markets Direct Research

1  2    4    6  7  8  9  10  
Irritable Bowel Syndrome - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... information on the therapeutic development for Irritable Bowel Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Refractory Leukemia - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Refractory Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Hepatitis A - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Systemic Mastocytosis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Systemic Mastocytosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Gingivitis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... Gingivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Radiodermatitis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... Radiodermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Acute Coronary Syndrome - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... information on the therapeutic development for Acute Coronary Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Insomnia - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... Insomnia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Haemophilus Influenzae Type b Infections - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Haemophilus Influenzae Type b Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Polycystic Kidney Disease - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... information on the therapeutic development for Polycystic Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Ewing Sarcoma - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... therapeutic development for Ewing Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Low Back Pain - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... information on the therapeutic development for Low Back Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... therapeutic development for Leishmaniasis (Kala-Azar), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Bipolar Disorder (Manic Depression), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Diphtheria - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... Diphtheria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Aspergillosis - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... Aspergillosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Critical Limb Ischemia - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... information on the therapeutic development for Critical Limb Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), complete with comparative analysis at various ...  |  read more...
USD 2,000
Diabetic Neuropathy - Pipeline Review, H1 2015
6/10/2015 | published by: Global Markets Direct
... therapeutic development for Diabetic Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Malignant Mesothelioma - Pipeline Review, H1 2015
5/29/2015 | published by: Global Markets Direct
... therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Enterococcus Faecium Infections - Pipeline Review, H1 2015
5/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Fragile X Syndrome - Pipeline Review, H1 2015
5/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Fragile X Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015
5/29/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!